V009-3919 Screening compound: N-butyl-2-({[(4-tert-butylphenyl)methyl](3,3-diphenylpropyl)amino}methyl)-1,3-thiazole-4-carboxamide

V009-3919 Screening compound: N-butyl-2-({[(4-tert-butylphenyl)methyl](3,3-diphenylpropyl)amino}methyl)-1,3-thiazole-4-carboxamide
V009-3919 Screening compound: N-butyl-2-({[(4-tert-butylphenyl)methyl](3,3-diphenylpropyl)amino}methyl)-1,3-thiazole-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V009-3919
N-butyl-2-({[(4-tert-butylphenyl)methyl](3,3-diphenylpropyl)amino}methyl)-1,3-thiazole-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V009-3919

Molecular Formula

C35H43N3OS (C35 H43 N3 OS)

Compound Name

N-butyl-2-({[(4-tert-butylphenyl)methyl](3,3-diphenylpropyl)amino}methyl)-1,3-thiazole-4-carboxamide

IUPAC name

N-butyl-2-({[(4-tert-butylphenyl)methyl](33-diphenylpropyl)amino}methyl)-13-thiazole-4-carboxamide

SMILES

CCCCNC(c1csc(CN(CCC(c2ccccc2)c2ccccc2)Cc2ccc(C(C)(C)C)cc2)n1)=O

InChI

InChI=1S/C35H43N3OS/c1-5-6-22-36-34(39)32-26-40-33(37-32)25-38(24-27-17-19-30(20-18-27)35(2,3)4)23-21-31(28-13-9-7-10-14-28)29-15-11-8-12-16-29/h7-20,26,31H,5-6,21-25H2,1-4H3,(H,36,39)

InChI Key

LTLBWNNKXLMXRY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19766790

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

553.81

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

15.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

8.729

Distribution Coefficient, logD

8.728

Water Solubility, LogSw

-5.80

Polar Surface Area

38.413

Acid Dissociation Constant (pKa)

14.34

Base Dissociation Constant (pKb)

4.24

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

37.10

V009-3919 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

DGK Inhibitors Library (10558 compounds)

KRAS-Targeted Library (16000 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with V009-3919 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V009-3919?
Check Price and Availability of V009-3919, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V009-3919 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V009-3919
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V009-3919
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V009-3919 available by request